As With HIV, New York State Was Set to Lead the Nation to End Hepatitis C. But Why Haven’t the Recommendations Been Made Public?
Activist and member of the state task force Annette Gaudino would like the public to know.
Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.
Oral Arguments in Antitrust Case Against HIV Drug Companies Began Last Week. Plaintiff Peter Staley Explains the Case
The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.
Descovy’s approval for PrEP showcases real-life ramifications of leaving trans people out of research. But including trans people is about more than just saying trans people are welcome, says researcher Brian Minalga.
“I’m not a physician. … We can diagnose and treat, but fundamentally we are taught to care.”
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
The HIV services organization Housing Works implemented a hepatitis C treatment program in New York City, with very high completion rates.
One New York-based provider who works specifically with trans and gender non-conforming patients outlines what needs to change in the health care world to get Black trans women the care they deserve.
Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.
For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.